-
-
-
-
-
-
-
Amicus Therapeutics Announces First Quarter 2022 Financial Results
-
-
-
-
-
-
-
Amicus Therapeutics (FOLD) Announces EMA Validates Amicus Therapeutics Marketing Authorization Applications for AT-GAA for the Treatment of Pompe Disease
-
-
-
-
-
-
-
BofA Would Buy These 4 SMid Cap Biotechs on the Pullback
-
-
-
-
-
-
15,434 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

